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a  b  s  t  r  a  c  t
INTRODUCTION:  Inﬂammatory  pseudotumor  (IPT)  of the  liver  is  a rare  and  benign  disease  that  has  a
good  prognosis.  It is  often  difﬁcult  to distinguish  IPT  from  hepatic  malignancies,  such  as hepatocellular
carcinoma  (HCC),  because  speciﬁc  clinical  symptoms  are absent  and  the  diseases’  radiological  ﬁndings  can
be similar.  IPT  is  particularly  difﬁcult  to  distinguish  from  HCC  in  livers  with  hepatitis  C virus  (HCV)-related
cirrhosis.  We  report  a case  of  IPT of the  liver  that  mimicked  HCV-related  HCC  recurrence.
PRESENTATION  OF  CASE:  A  78-year-old  asymptomatic  Japanese  man  who  had  undergone  hepatectomy  for
HCV-related HCCs  (moderately  differentiated  type)  in segments  7 and 5 four  and  a  half  years  previously
was  referred  to our  hospital  for treatment  of  a  30-mm  enhanced  tumor  in segment  5  (a typical  HCC
pattern).  The  tumor  was  identiﬁed  via  abdominal  dynamic  computed  tomography  (CT)  and  CT  with
hepatic  arteriography  and  arterial  portography.  Thereafter,  liver  segmentectomy  5 was  performed,  and
the  histopathological  diagnosis  was  a 10-mm  IPT  of  the liver.  After  1.5 years,  magnetic  resonance  imaging
revealed  two new  enhanced  lesions  in  segment  8, which  showed  the typical  pattern  of HCC.  Because
these  lesions  grew  in size  for 3 months,  liver  segmentectomy  8  was  performed  for  HCC  recurrence.
Histopathological  examination  showed  that both  lesions  were HCCs.
CONCLUSION:  HCV-related  HCC  has  a high  rate  of  multicentric  recurrence.  Our  experience  suggests  that,
when a  hepatic  lesion  is  suspected  to be HCC,  surgical  resection  should  be considered  for  curative  treat-
ment  and  to rule out malignancy,  even  if  the  lesion  may  be  an  IPT.
© 2016  The  Authors.  Published  by  Elsevier  Ltd.  on behalf  of IJS  Publishing  Group  Ltd.  This  is an  open
he CCaccess  article  under  t
. IntroductionInﬂammatory pseudotumor (IPT) of the liver is a rare and benign
esion that has a good prognosis. IPT is characterized by chronic
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tandardized uptake value; ESR, erythrocyte sedimentation rate.
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inﬁltration of inﬂammatory cells and areas of ﬁbrosis [1,2]. The
etiology of IPT remains uncertain, although infectious conditions,
autoimmune phenomenon, and systemic inﬂammatory response
syndrome have been suggested as possible causes [3–5]. As a con-
sequence of similar radiological features, IPT of the liver is often
difﬁcult to differentiate from other malignant diseases, such as hep-
atocellular carcinoma (HCC) [6,7], intrahepatic cholangiocarcinoma
[1,8], and metastatic tumor [9]. It is extremely difﬁcult to estab-
lish an accurate preoperative diagnosis of IPT based on radiological
imaging, particularly for cases in which IPT occurs in a liver that is
affected by chronic viral hepatitis [6]. Here, we report a rare case
of IPT of the liver that occurred during the course of treatment for
hepatitis C virus (HCV)-related HCC.2. Presentation of case
A 78-year-old Japanese man  was referred to our hospital for
treatment of a hepatic tumor in segment 5, which was identi-
Group Ltd. This is an open access article under the CC BY-NC-ND license (http://
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oig. 1. Abdominal dynamic computed tomographic (CT) image showing a 30-mm
omogeneously enhanced lesion at an early phase (a), and was washed out at a lat
uring  arterial portography revealed a perfusion defect (d). No other tumors were f
ed via abdominal computed tomography (CT), although he had
o complaints or symptoms. Four and a half years prior, he had
ndergone hepatectomy for HCCs (moderately differentiated type)
n segments 7 and 5; the operation consisted of segmentectomy 7,
edge resection in segment 5, and cholecystectomy (ﬁrst opera-
ion). The patient had been positive for HCV antibody and negative
or HCV-RNA without interferon based therapy.
In laboratory studies, no inﬂammatory response was observed,
he white blood cell count was 5060/mm3, and the C-reactive pro-
ein (CRP) level was 0.16 mg/dL. Additional laboratory results were
s follows: total bilirubin, 1.1 mg/dL; aspartate aminotransferase,
6 IU/L; alanine aminotransferase, 21 IU/L; alkaline phosphatase,
66 IU/L; and -glutamyl transpeptidase, 39 IU/L. Levels of alpha-
etoprotein (AFP; 5.7 ng/mL) and protein induced by vitamin K
bsence-2 (PIVKA-II; 13 mAU/mL) were within their normal limits.
Abdominal dynamic CT revealed a 30-mm contrast-enhanced
pace-occupying lesion (SOL) in segment 5 at an early phase. The
esion presented with washout at a late phase (Fig. 1a, b). CT hep-
tic arteriography (CTHA) was performed to allow more detailed
xamination, revealing a hypervascular tumor. Further, CT during
rterial portography (CTAP) revealed a perfusion defect in segment
 (Fig. 1c, d).
The tumor in segment 5 was diagnosed as an HCC recurrence
ased on radiological ﬁndings, as it showed the typical pattern of
oderately differentiated HCC. Segmentectomy 5 was  therefore
erformed (a second operation). Histopathological examination
evealed inﬂammatory granulation tissue in a 10-mm yellow-
rown nodular lesion. The ﬁnal diagnosis was  IPT of the liver
Fig. 2). Inﬁltrating plasma cells were positive for immunoglobu-
in G4 (IgG4) on immunohistochemistry. The nontumor area of the
pecimen showed chronic hepatitis, as indicated by slight lympho-
yte permeation around the portal vein.The subsequent follow-up was conducted using contrast-
nhanced magnetic resonance imaging (MRI) because a contrast-
nhanced CT had caused allergic symptoms after the second
peration. One year and 6 months following the second surgery,e-occupying lesion (arrowhead) in segment 5 of the liver, which was visible as a
se (b). CT during hepatic arteriography revealed a hypervascular tumor (c), and CT
in the examination.
two new lesions appeared in segment 8. Abdominal contrast-
enhanced MRI  revealed a tumor (diameter, 16 mm)  near the border
of segment 8 and a tumor (diameter, 10 mm)  below the hepatic
dome. Both tumors showed contrast enhancement at the arterial
phase and washout at the hepatic cell phase. In a follow-up MRI
that was performed 3 months later, the tumor near the border of
segment 8 was  observed to have grown from 16 to 20 mm,  and the
tumor below the hepatic dome was observed to have grown from
10 to 17 mm (Fig. 3). Sonazoid-enhanced ultrasonography showed
the tumor near the border of segment 8 as a 15-mm hyperechoic
lesion at the early vascular phase, as well as a defect lesion at the late
Kupffer phase. Positron emission tomography/computed tomog-
raphy (PET-CT) revealed uptake in the lesion near the border of
segment 8, with a maximum standardized uptake value (SUVmax)
of 5.0 mC/kg body weight. Further, PET-CT showed uptake in the
lesion below the hepatic dome, with an SUVmax of 2.9 mC/kg. The
levels of tumor markers AFP and PIVKA-II were within the normal
limits during follow-up.
Because HCC recurrence was strongly suspected, liver seg-
mentectomy 8 was performed (a third operation), including the
two growing lesions. Histopathological examination determined
that both lesions in segment 8 were HCCs (moderately differenti-
ated type). The nontumor area of the specimen showed necrotic
inﬂammatory reactions with bridging ﬁbrosis and bridging necro-
sis around the portal vein. Currently, at 2 years after the most recent
surgery, the patient has shown no recurrence.
3. Discussion
IPT of the liver was  ﬁrst described by Pack and Baker in 1953
[10]. Since the ﬁrst report of this rate entity, more than 200 cases
of IPT of the liver have been reported in the English literature [11].
However, the etiology of IPT remains unknown. Some cases have
been associated with abscess formation [12], bacterial infection [4],
autoimmune reactions [3], and viral infections, such as with hep-
atitis B virus [11], HCV [7,13], and Epstein-Barr virus [14]. It has led
CASE  REPORT  –  OPEN  ACCESS
98 N. Honmyo et al. / International Journal of Surgery Case Reports 20 (2016) 96–100
Fig. 2. Cut surface of the resected specimen showing a 10- × 10-mm yellow-brown nodular lesion (a). The histopathological ﬁnding showed ﬁbrosis and numerous inﬁltrating
lymphocytes and plasma cells in the tumor (b: hematoxylin and eosin stain, ×400). Many inﬁltrating plasma cells were positive for IgG4 (c: on immunohistochemistry, ×400).
Fig. 3. Contrast-enhanced magnetic resonance image (MRI) showing two new lesions with perfusion defect at the hepatic cell phase and good enhancement at the arterial
phase.  The white arrowhead indicates the 16-mm tumor near the border of segment 8 (a: hepatic cell phase, a′: arterial phase). The black arrowhead indicates the 10-mm





af  segment 8 had grown to 20 mm (c: white arrow) and that the lesion below the h
o the suggestion that IPTs of the liver may  be caused by any local
r systemic inﬂammatory reactions.
In several retrospective reports, IPTs of the liver were frequently
ssociated with symptoms such as abdominal pain, fever, malaise,
nd weight loss; nonetheless, the percentage of asymptomatic dome had grown to 17 mm (d: black arrow).
cases was not small [15–17]. The most common abnormal labora-
tory ﬁndings were an increased serum erythrocyte sedimentation
rate (ESR) and/or CRP level. In the present case, the CRP level was
not elevated and was  within the normal range before the second
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peration. However, the ESR was not surveyed during the follow-up
eriod.
The present case was  completely asymptomatic, and was iden-
iﬁed through an incidental CT ﬁnding during follow-up for HCC.
he patient had not had any recent episode of bacterial infection,
uch as with cholangitis. We  regarded the inﬂammatory reactions
o HCV activity as the cause of IPT in this case. Unlike the disease sta-
us at the second operation, the histopathological characteristics,
CV activity, and ﬁbrosis in the nontumor area were observed to be
rogressive at the third operation. Thus, we speculated that latent
ut active hepatitis had actually been present, despite the negative
CV-RNA test result. To the best of our knowledge, IPT after HCV
nfection has only been described in two cases in the English lit-
rature. Both cases were originally suspected to be HCC and were
nally diagnosed as IPT based on liver biopsy ﬁndings. However, the
peciﬁc mechanisms of IPT development after HCV infection were
ot discussed [7,13]. IgG4-positive inﬁltrating plasma cells were
bserved in the pseudotumor on immunohistochemistry, indicat-
ng the possibility of IgG4-related disease. IgG4-related disease is
haracterized by abundant IgG4-positive plasma cell inﬁltration
nd a high serum IgG4 level [3]. Hepatic IPTs with IgG4-related
isease are usually associated with sclerosing cholangitis. In the
resent case, no clinical or histopathological evidence of sclerosing
holangitis was found, and the serum IgG4 level was 30.3 mg/dL,
hich is within the normal range (4.8–105.0 mg/dL). Thus, this
ase was unlikely to have been IgG4-related disease. Instead, it is
ore likely to have been a nonspeciﬁc IPT that included numerous
gG4-positive plasma cells.
To date, two cases of IPT with synchronous HCC have been
eported. One case involved co-localization of IPT and HCC in the
iver of a patient with alcoholic hepatitis [18], while the other case
as only identiﬁed intraoperatively in a patient with hepatitis B
irus-related HCC [2]. The occurrence of IPT with asynchronous HCC
uring the course of HCC treatment has not been reported previ-
usly. HCV-related HCC is widely known to have a high multicentric
ccurrence rate. It is extremely difﬁcult to obtain an accurate pre-
perative diagnosis of IPT that occurs during HCC treatment, and
esection of the lesion is appropriate. In the present case, we
bserved bridging ﬁbrosis and necrosis of the nontumor area of
he specimen from the third operation, suggesting the possibility
f HCC recurrence in the future.
According to previous reports, IPTs have had an indeﬁnite
ppearance in radiological examinations [5,19]. In the present case,
he IPT showed the typical pattern of moderately differentiated
CC. When a hepatic mass has been diagnosed as HCC according
o radiographic ﬁndings, resection of the lesion is usually selected
ithout ﬁne-needle biopsy, to prevent the risk of neoplastic seed-
ng or morbidity such as bleeding.
The appropriate treatment protocol for IPT is uncertain, and
he management of IPT is controversial [2,6]. Conservative treat-
ents with antibiotics or nonsteroidal anti-inﬂammatory drugs
ave been reported in some cases that included tumor regression.
n the present case, the tumor diameter was 30 mm at the pre-
perative diagnosis, although regression to 10 mm was observed
n the resected specimen from the second operation. If a follow-
p examination had been performed just prior to the second
peration, the extent of regression might have been observed.
owever, rapid treatment was required because the treatment
arget was malignant disease. Before the third operation, twice
ontrast-enhanced MRI, contrast ultrasonography, and PET-CT scan
ere performed to improve the precision of the preoperative diag-
osis. Based on the imaging results, the resected lesions were
onsidered to be HCC recurrences. Thus, curative resection was
erformed to avoid missing the operable period. IPTs that are
reated conservatively have a potential for metastasis, and the
o-localization of IPT and HCC has been reported [18]. SurgicalPEN  ACCESS
rgery Case Reports 20 (2016) 96–100 99
resection is needed, both for curative treatment and to rule out
malignancy.
4. Conclusion
We have reported a rare case of IPT of the liver that occurred
during the course of HCV-related HCC treatment. When a hepatic
lesion is suspected to be HCC, surgical resection should be consid-
ered for curative treatment and to rule out malignancy, even if the
lesion may  be an IPT.
Conﬂict of interest
None of the authors has anything to disclose.
Funding
None of the authors has anything to disclose.
Ethical approval
All procedures used in this research were approved by the Eth-
ical Committee of Hiroshima University Hospital.
Consent
Written informed consent was obtained from the patient for
the publication of this case report and any accompanying images.
A copy of the written consent form is available for review by the
Editor-in-Chief of this journal.
Authors’ contributions
Honmyo, Kuroda, Kobayashi, and Ohdan were responsible for
the conception and design of this study. Ishiyama, Ide, Tahara,
and Ohira participated in the data acquisition. Honmyo, Kuroda,
Kobayashi, Tashiro, and Ohdan performed the analysis and inter-
pretation of the data. Kuroda and Kobayashi helped to draft the
manuscript. Arihiro analyzed the pathological ﬁndings. Kuroda,
Kobayashi, and Ohdan coordinated the study and critically revised
the manuscript. All of the authors read and approved the ﬁnal
manuscript.
Guarantor
Tsuyoshi Kobayashi has accepted full responsibility for this work




[1] K.S. Ahn, K.J. Kang, Y.H. Kim, et al., Inﬂammatory pseudotumors mimicking
intrahepatic cholangiocarcinoma of the liver; IgG4-positivity and its clinical
signiﬁcance, J. Hepatobiliary Pancreat. Sci. 19 (2012) 405–412.
[2] G. Torzilli, K. Inoue, Y. Midorikawa, A.M. Hui, T. Takayama, M. Makuuchi,
Inﬂammatory pseudotumors of the liver: prevalence and clinical impact in
surgical patients, Hepatogastroenterology 48 (2001) 1118–1123.
[3] Y. Zen, T. Fujii, Y. Sato, S. Masuda, Y. Nakanuma, Pathological classiﬁcation of
hepatic inﬂammatory pseudotumor with respect to IgG4-related disease,
Mod. Pathol. 20 (2007) 884–894.
[4] J.E. White, C.W. Chase, J.E. Kelley, W.B. Brock, M.O. Clark, Inﬂammatory
pseudotumor of the liver associated with extrahepatic infection, South. Med.
J.  90 (1997) 23–29.
[5] R. Horiuchi, T. Uchida, T. Kojima, T. Shikata, Inﬂammatory pseudotumor of the
liver: clinicopathologic study and review of the literature, Cancer 65 (1990)
1583–1590.
 –  O















00 N. Honmyo et al. / International Journa
[6] Q. Ke, L. Fan, X. Duan, Z. He, S. Zheng, Inﬂammatory pseudotumor mimicking
primary hepatic malignant tumor with hepatitis B virus-related cirrhosis: a
case report, Oncol. Lett. 6 (2013) 550–552.
[7] S.R. Kim, Y. Hayashi, M. Kudo, et al., Inﬂammatory pseudotumor of the liver in
a  patient with chronic hepatitis C: difﬁculty in differentiating it from
hepatocellular carcinoma, Pathol. Int. 49 (1999) 726–730.
[8] K. Kai, S. Matsuyama, T. Ohtsuka, K. Kitahara, D. Mori, K. Miyazaki, Multiple
inﬂammatory pseudotumor of the liver, mimicking cholangiocarcinoma with
tumor embolus in the hepatic vein: report of a case, Surg. Today 37 (2007)
530–533.
[9] Y. Matsuo, M.  Sato, T. Shibata, et al., Inﬂammatory pseudotumor of the liver
diagnosed as metastatic liver tumor in a patient with a gastrointestinal
stromal tumor of the rectum: report of a case, World J. Surg. Oncol. 12 (2014)
140.
10] G.T. Pack, H.W. Baker, Total right hepatic lobectomy; report of a case, Ann.
Surg. 138 (1953) 253–258.
11] T. Akatsu, G. Wakabayashi, A. Tanimoto, K. Kameyama, M.  Kitajima,
Inﬂammatory pseudotumor of the liver masquerading as hepatocellular
carcinoma after a hepatitis B virus infection: report of a case, Surg. Today 36
(2006) 1028–1031.
12] F. Jover Diaz, C. Martin Gonzalez, M.J. Mayol Belda, J.M. Cuadrado Pastor,
Multiple inﬂammatory liver pseudotumors and Enterococcus durans
bacteremia, Gastroenterol. Hepatol. 32 (2009) 97–100.
pen Access
his article is published Open Access at sciencedirect.com. It is distrib
ermits unrestricted non commercial use, distribution, and reproduct
redited.PEN  ACCESS
rgery Case Reports 20 (2016) 96–100
13] G. Schneider, P. Fries, P. Samaras, K. Remberger, M.  Uder, B. Kramann,
Inﬂammatory pseudotumor of the liver in a patient with congenital
granulocytopenia and HCV infection, Eur. J. Radiol. 48 (2003) 293–298.
14] J. Selves, F. Meggetto, P. Brousset, et al., Inﬂammatory pseudotumor of the
liver: evidence for follicular dendritic reticulum cell proliferation associated
with clonal Epstein-Barr virus, Am.  J. Surg. Pathol. 20 (1996) 747–753.
15] J.Y. Park, M.S. Choi, Y.S. Lim, et al., Clinical features, image ﬁndings, and
prognosis of inﬂammatory pseudotumor of the liver: a multicenter
experience of 45 cases, Gut Liver 8 (2014) 58–63.
16] L. Tang, E.C. Lai, W.M. Cong, et al., Inﬂammatory myoﬁbroblastic tumor of the
liver: a cohort study, World J. Surg. 34 (2010) 309–313.
17] P.J. Goldsmith, A. Loganathan, M.  Jacob, et al., Inﬂammatory pseudotumours
of the liver: a spectrum of presentation and management options, Eur. J. Surg.
Oncol. 35 (2009) 1295–1298.
18] Y. Takahashi, J. Iwata, Y. Shima, et al., Necrotic hepatocellular carcinoma
occurring within an inﬂammatory pseudotumor-like nodule, Intern. Med. 52
(2013) 551–554.
19] T. Fukuya, H. Honda, T. Matsumata, et al., Diagnosis of inﬂammatory
pseudotumor of the liver: value of CT, Am.  J. Roentgenol. 163 (1994)
1087–1091.
uted under the IJSCR Supplemental terms and conditions, which
ion in any medium, provided the original authors and source are
